The diagnosis and assessment of individuals prodromal for schizophrenic psychosis

CNS Spectrums

Volumn 9, Issue 8, 2004, Pages 588-594

  Addington, Jean ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DISEASE PREDISPOSITION; DISEASE SEVERITY; EARLY DIAGNOSIS; GENETIC RISK; HIGH RISK POPULATION; HUMAN; PRIORITY JOURNAL; PSYCHOSIS; RATING SCALE; REVIEW; SCHIZOPHRENIA; SYMPTOM;

EID: 4444381520     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900002753     Document Type: Review

References (28)

1. McGorry PD, Jackson HJ, eds. The Recognition and Management of Early Psychosis. Cambridge, England: Cambridge University Press; 1999.
2. McGlashan TH, Zipursky R, Perkins DO, et al. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design. Schizophr Res. 2003;61:7-18.
3. Cornblatt B, Obuchowski M. Update of high-risk research: 1987-1997. International Review of Psychiatry. 1997;9:437-447.
4. Yung AR, McGorry PD, McFarlane CA, Patton GC, Rakkar A. Monitoring and care of young people at incipient risk of psychosis. Schizophr Bull. 1996;22:283-303.
5. Yung AR, McGorry PD. The initial prodrome in psychosis: descriptive and qualitative aspects. Aust N Z J Psychiatry. 1996;30:587-599.
6. Yung AR, McGorry PD. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull. 1996;22:353-370.
7. McGorry PD, Yung A, Phillips L. Ethics and early intervention in psychosis: keeping up the pace and staying in step. Schizophr Res. 2001;51:17-29.
8. Yung AR, Phillips L, McGorry PD, et al. Prediction of psychosis. Br J Psychiatry. 1998;172(suppl 33):14-20.
9. Miller TJ, McGlashan TH, Rosen JL, et al. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry. 2002;159:863-865.
10. Yung AR, Phillips LJ, Yuen H, et al. Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophr Res. 2003;60:21-32.
11. Schaffner KF, McGorry PD. Preventing severe mental illnesses - new prospects and ethical challenges. Schizophr Res. 2001;513-15.
12. Chapman LJ, Chapman JP. The search for symptoms predictive of schizophrenia. Schizophr 1987;13:497-503.
13. Chapman LJ, Chapman JP, Kwapil TR, Eckblad M, Zinser MC. Putatively psychosis-prone subjects 10 years later. J Abnorm Psychol. 1994;103:171-183.
14. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed-rev. Washington, DC: American Psychiatric Association; 1987.
15. Jackson HJ, McGorry PD, Dudgeon P. Prodromal symptoms of schizophrenia in first-episode psychosis: prevalence and specificity. Compr Psychiatry. 1995;36:241-250.
16. Yung AR, Philips LJ, McGorry PD, Ward JL, Thompson K. The Comprehensive Assessment of At-Risk Mental States (CAARMS). Melbourne, Australia: University of Melbourne; 2000.
17. Diagnostic and Statistical Manual of Menial Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
18. Miller TJ, McGlashan TH, Woods SW, et al. Symptom assessment in schizophrenic prodromal states. Psychiatr Q. 1999;70:273-287.
19. McGlashan TH. Psychosis treatment prior to psychosis onset: ethical issues. Schizophr Res. 2001;51:47-54.
20. Hawkins KA, McGlashan TH, Quinlan D, et al. Factorial structure of the Scale of Prodromal Symptoms. Schizophr Res. 2004;61:339-347.
21. Gross G. The 'basic' symptoms of schizophrenia. Br J Psychiatry. 1989;155(suppl):21-25.
22. Klosterkötter J. The meaning of basic symptoms for the development of schizophrenic psychosis. Neur Psychiatr Brain Res. 1992;1:30-41.
23. Klosterkötter J, Gross G, Huber G, Wieneke A, Steinmeyer EM, Schultze-Lutter F. Evaluation of the 'Bonn Scale for the Assessment of Basic Symptoms-BSABS' as an instrument for the assessment of schizophrenia proneness: a review of recent findings. Neur Psychiatr Brain Res. 1997;5:137-150.
24. Klosterkötter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry. 2001;58:158-164.
25. Wieneke A, Schultz-Lutter F, Picker H, Steinmeyer EM, Klosterkötter J. The Schizophrenia Prediction Instrument (SPI-A): first preliminary results of the evaluation study. Schizophr Res. 2002;53:37.
26. Addington J. The prodromal stage of psychotic illness: observation, detection, or intervention? J Psychiatry Neurosci. 2003;28:93-97.
27. McGorry PD, Yung A, Phillips L, et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry. 2002;59:921-928.
28. Woods SW, Breier A, Zipursky RB, et al. Randomized trial of olanzapine vs placebo in the symptomatic treatment of patients meeting criteria for the schizophrenic prodrome. Biol Psychiatry. 2003;54:453-464.